Valuation (55%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.83 | N/A |
| PEG Ratio (TTM) | 46.06 | N/A |
| P/S Ratio (TTM) | 3.99 | N/A |
| P/B Ratio (TTM) | 1.99 | N/A |
| P/FCF Ratio (TTM) | -4.67 | N/A |
| Price to 5YR AVG Earnings Ratio | 1.86 | N/A |
| Price to 5YR AVG FCF Ratio | 27.27 | N/A |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.28% | N/A |
| ROE (TTM) | 15.92% | N/A |
| Net Profit Margin (TTM) | 31.61% | N/A |
| ROIC 5YR AVG | 18.25% | N/A |
Growth (55%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 6.45% | 24.91% | 17.53% |
| Revenue | 1.02% | 3.83% | 6.09% |
| Net Income | 5.32% | 19.36% | 13.51% |
| Cash Flow | -159.40% | -427.12% | -266.42% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 9.48 | N/A |
| Quick Ratio (TTM) | 9.48 | N/A |
| D/E Ratio (TTM) | 1.33 | N/A |
| Interest Coverage (TTM) | 0.99 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.52 | N/A |
| LTL to 5YR AVG FCF | 15.76 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.84% | N/A |